CSL Behring GmbH, a leading global biotechnology company, is headquartered in Austria (AT) and operates extensively across Europe, North America, and Asia. Founded in 1904, CSL Behring has established itself as a pioneer in the development of innovative therapies for rare and serious medical conditions, particularly in the fields of immunology, haematology, and respiratory health. The company is renowned for its high-quality plasma-derived therapies, including immunoglobulins and clotting factor concentrates, which are essential for patients with immune deficiencies and bleeding disorders. CSL Behring's commitment to research and development has positioned it as a market leader, with notable achievements in advancing treatment options and improving patient outcomes. With a strong focus on patient care and scientific excellence, CSL Behring continues to make significant contributions to the biopharmaceutical industry.
We don't have data for CSL Behring GmbH, but we can show you information about their parent organization instead.
View parent company